Board of Directors
Mr. Desai is a Senior Partner at J. Sagar Associates, a national law firm in India. He specializes in mergers and acquisitions, derivatives, corporate and financial laws and international commercial arbitration. Some of the listed companies in which Mr. Desai is a Director include Sterlite Industries (India), The Great Eastern Shipping Company, Praj Industries, Edelweiss Capital and Adani Enterprises.
MARY E. KLOTMAN, MD
A pioneering physician-scientist, Dr. Klotman’s research interests are focused on the molecular pathogenesis of Human Immunodeficiency Virus 1 (HIV-1) infection. Among many important contributions to this field, Dr. Klotman and her team demonstrated that HIV resides in and evolves separately in kidney cells, a critical step in HIV-associated kidney disease. Most recently, her group has been defining the role of integrase-defective lentiviral vectors for the delivery of an HIV vaccine.
Dr. Klotman is past president of the Association of American Physicians and past president of the Association of Professors of Medicine. She was elected to membership in the Academy of Medicine in 2014. Dr. Klotman is a former president of the Duke Medical Alumni Association and received a Duke University School of Medicine Distinguished Alumni Award in 2015.
KEITH A. JONES (Tony), MD
Dr. Keith (Tony) Jones received his Medical Degree from the University of Alabama (UA) School of Medicine in 1986. He completed an anesthesiology residency and postgraduate studies at Mayo Clinic, which included advanced training in Neuroanesthesia and a Postdoctoral NIH Research fellowship. Dr. Jones was a member of the faculty of the Mayo Clinic College of Medicine and practiced in the Department of Anesthesiology at Mayo Clinic for 15 year, and then served as the Alfred Habeeb Professor and Chair of the Department of Anesthesiology and Perioperative Medicine at the University of Alabama at Birmingham (UAB) from July 2006 to October 2017. Dr.Jones is currently the President of the University of Alabama Health Services Foundation and Chief Physician Executive of the UAB Health System. Dr. Jones also serves on the Joint Operating Leadership Council for UAB Medicine and the Executive Cabinet of the UAB Health System, as well as Senior Associate Dean for Clinical Affairs in the UA School of Medicine.
A former member of the organization’s advisory board, King joins the board of investors after serving as the senior vice president of integration at Aetna, one of the nation’s largest health plans. His responsibilities at Aetna included leading the provider network strategy and implementation planning for the Humana acquisition. King also had profit and loss responsibility for National Accounts, a division serving Aetna’s largest customers. Additionally, he served as head of Aetna’s provider network strategy and contracting policies.
Mr. Utpal Sheth serves as the Chief Executive Officer at Rare Enterprises and is responsible for Investment Management, Risk Management and Institutionalization. Mr. Sheth started his professional career at erstwhile ASK Financial Consultants and went on to be the Head of Research there. Mr. Sheth has been Independent Director of Cineline India Limited since 2010. Mr. Sheth served as a Non-Executive Independent Director at Cinemax India Limited from 2010 to 2013. He has been a faculty member at the BSE Training Institute, UTI Institute of Capital Market, National Institute of Financial Management, IIS Institute of Management and other such organizations.
Mr. Amit Goela has a distinguished profile in the Indian financial and securities market with over 30 years of experience. He was associated with several leading corporate houses on strategy planning and investments. He is associated with Rare Enterprises and heads the research and investment team at Rare Enterprises. Mr. Goela has been an advisor for various companies in the areas of macro-economics, equity research, both public and private markets, corporate restructuring, investments and arrangements including mergers and acquisitions, and advisory for stakeholder value creation. He is currently on the board of VA Tech Wabag, a company focused on water treatment, in India. He has an MBA in finance from the University of North Florida.
A Fellow Member of the Institute of Chartered Accountants of India, Mr. Jhunjhunwala is a veteran Chartered Accountant, specializing in taxation and commercial law, since 1979. He serves as a director and advisor at several companies and many social organizations. He is the President of ICL Education Society which supports education through a college and two schools in Navi Mumbai, with a staff of 300 and more than 10,000 students.
SACHIN K. GUPTA
Founder, CEO & Whole-time Director
Mr. Gupta co-founded IKS Health in 2007 with the goal of building the leading technology enabled process optimization business that helps healthcare providers operate more efficiently. Armed with a unique blend of entrepreneurial spirit, executive acumen and strategic vision, Mr. Gupta continues to shape and lead the organization on the path of rapid growth and success.
Chief Growth Officer & Whole-time Director
In 2007, Mr. Benardello co-founded IKS Health and remains at the helm of the company’s global Healthcare Solutions organization. He brings more than 20 years of executive management experience to the organization and has a proven track record enabling clients, including organizations ranging from start-ups to the Fortune 500, structured both for profit and not-for-profit, to navigate change in their industries successfully and experience significant growth.